FundingWatcher
Home / Investors / Post IPO investors / Post IPO investors in Massachusetts, United States

Post IPO investors in Massachusetts, United States

Updated 16 Nov 2026

Reset

Venture funds

1 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Founder Collective
Founder Collective backs seed-stage startups, with recent investments including Baselayer, WHOOP and Ownwell.
Cambridge, United States
Artificial intelligence, Commerce Seed, Early stage venture, Late stage venture 6% 5

Table 1. Post IPO investors in Massachusetts, United States: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Post IPO investors in Massachusetts, United States
One-time CSV
  • 48 firms, 46 with a website
  • 29 firm email addresses
  • 35 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-post-ipo-investors-massachusetts-united-states.csv48 rows × 15 columns
InvestorTypeLocationEmailPhone
Atlas VentureVenture capital firmCambridge, United States•••@atlasventure.com857 20•••
RA Capital ManagementStartup incubatorBoston, United States•••@racap.com617.77•••
Founder CollectiveVenture capital firmCambridge, United States•••@foundercollective.com(617) •••
Highland Capital PartnersVenture capital firmLexington, United States•••@hcp.com(781) •••
North Bridge Venture Partners & Growth EquityVenture capital firmWellesley, United States•••@northbridge.com781.29•••
SV Health InvestorsPrivate equity firmBoston, United States•••@svlsa.com+1 617•••
HarbourVest PartnersPrivate equity firmBoston, United States•••@harbourvest.com+1 617•••
Advent InternationalPrivate equity firmBoston, United States•••@adventinternational.com212 81•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-stage-post-ipo-investors-massachusetts-united-states-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
Atlas VentureB••• B•••Partnerb•••@atlasventure.comIn the CSV
RA Capital ManagementP••• K•••Managing Partnerp•••@racap.comIn the CSV
Founder CollectiveA••• H•••General Partnera•••@foundercollective.comIn the CSV
Highland Capital PartnersC••• D•••Co-Founder & Managing Partnerc•••@hcp.comIn the CSV
North Bridge Venture Partners & Growth EquityR••• D•••General Partnerr•••@northbridge.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

48
Investors
29
With email
35
With phone
13
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Post IPO investors in Massachusetts, United States

30 of 48, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Atlas Venture Venture capital firm Cambridge, United States Health care, Biotech Diagonal Therapeutics 1 638 179 199 •••@atlasventure.com 857 20••• In the CSV
2 Fidelity Investment bank Boston, United States Health care, Hardware Zipline International, Tenstorrent, SiMa.ai 7 586 178 285 +1-866••• In the CSV
3 RA Capital Management Startup incubator, Private equity firm Boston, United States Health care, Biotech Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics 9 544 183 243 •••@racap.com 617.77••• In the CSV
4 Founder Collective Venture capital firm Cambridge, United States Artificial intelligence, Commerce Baselayer, WHOOP, Ownwell 5 543 35 161 •••@foundercollective.com (617) ••• In the CSV
5 Highland Capital Partners Venture capital firm Lexington, United States Hardware, Commerce Tomorrow.io 1 507 157 154 •••@hcp.com (781) ••• In the CSV
6 North Bridge Venture Partners & Growth Equity Venture capital firm Wellesley, United States Hardware, Commerce Clothia, Ravel Law, Oracle Dyn 425 134 120 •••@northbridge.com 781.29••• In the CSV
7 SV Health Investors Private equity firm, Venture capital firm Boston, United States Health care, Biotech Alchemab Therapeutics 1 325 76 95 •••@svlsa.com +1 617••• In the CSV
8 TA Associates Private equity firm Boston, United States Hardware, Artificial intelligence Wunder Mobility, Stackline, Thinkproject 317 173 194 +1.617••• In the CSV
9 Flagship Pioneering Venture capital firm Cambridge, United States Biotech, Health care Inari, Prologue Medicines, Quotient Therapeutics 288 104 72 617-86••• In the CSV
10 Cormorant Asset Management Hedge fund Boston, United States Health care, Biotech Triveni Bio, Third Arc Bio, BlossomHill Therapeutics 4 276 58 141 In the CSV
11 HarbourVest Partners Private equity firm Boston, United States Fintech, Hardware Varo Bank 1 273 52 147 •••@harbourvest.com +1 617••• In the CSV
12 Advent International Private equity firm Boston, United States Fintech, Hardware Coralogix, KreditBee 2 234 97 89 •••@adventinternational.com 212 81••• In the CSV
13 SR One Venture capital firm Cambridge, United States Biotech, Health care Asceneuron 214 69 69 (610) ••• In the CSV
14 Bain Capital Private equity firm, Venture capital firm Boston, United States Fintech, Hardware Mintlify 1 198 89 89 •••@baincapital.com +1 617••• In the CSV
15 Omega Funds Secondary purchaser, Venture capital firm Boston, United States Biotech, Health care FoRx Therapeutics 1 161 37 75 •••@omegafunds.net In the CSV
16 Adage Capital Management Government investment office Boston, United States Artificial intelligence, Health care Welldoc 161 13 119 •••@adagecapital.com 617-86••• In the CSV
17 Third Rock Ventures Venture capital firm Boston, United States Biotech, Health care Terremoto Biosciences 1 154 69 44 •••@thirdrockventures.com (415) ••• In the CSV
18 HLM Venture Partners Venture capital firm Boston, United States Health care, Hardware ArroHealth, PatientPop, ClearDATA 138 41 51 •••@hlmvp.com 617-26••• In the CSV
19 Trustbridge Partners Private equity firm Boston, United States Education, Commerce Hope Medicine, Zilliz, huoban.com 122 44 21 •••@trustbridgepartners.com In the CSV
20 Eastward Capital Partners Venture debt fund West Newton, United States Hardware, Artificial intelligence STRIVE, IntelyCare, Crayon 122 9 48 •••@eastwardcp.com 617-96••• In the CSV
21 Sanofi Ventures Corporate venture arm Cambridge, United States Biotech, Health care i2o Therapeutics, Tisento Therapeutics, NGI 119 31 28 •••@gmail.com +1 617••• In the CSV
22 Johnson & Johnson Innovation Corporate venture arm Cambridge, United States Health care, Biotech ONL Therapeutics, Flindr Therapeutics, Asgard Therapeutics 118 39 26 In the CSV
23 RockPort Capital Venture capital firm Boston, United States Hardware, Biotech NewLeaf Symbiotics, EcoFactor, Gazelle 108 25 26 415-78••• In the CSV
24 Atreides Management Hedge fund, Venture capital firm Boston, United States Hardware, Cybersecurity DustPhotonics, Chain Reaction 89 15 9 •••@atreidesmgmt.com 617-42••• In the CSV
25 Eventide Private equity firm, Venture capital firm Boston, United States 64 14 36 •••@eventidefunds.com +1-877••• In the CSV
26 JDRF T1D Fund Venture capital firm Boston, United States Biotech, Health care i2o Therapeutics 54 13 14 •••@jdrf.org 212-68••• In the CSV
27 Agent Capital Venture capital firm Waltham, United States Health care, Biotech Foresight Diagnostics, āshibio, Cyrus Biotechnology 54 5 17 •••@agentcapital.com 844-69••• In the CSV
28 K2 HealthVentures Private equity firm, Venture capital firm Boston, United States Biotech, Health care Click Therapeutics 1 51 28 24 •••@k2hv.com In the CSV
29 Material Impact Venture capital firm Boston, United States Biotech, Hardware Actnano, Tierra Biosciences, Talus Renewables 45 22 3 In the CSV
30 PAR Capital Management Venture capital firm Boston, United States Software Journera, Routehappy 39 9 11 •••@parcapital.com (617) ••• In the CSV

Table 2. Post IPO investors in Massachusetts, United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 48.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 RA Capital Management Boston, United States 9 47 Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics
2 Fidelity Boston, United States 7 40 Zipline International, Tenstorrent, SiMa.ai
3 Founder Collective Cambridge, United States 5 119 Baselayer, WHOOP, Ownwell
4 Cormorant Asset Management Boston, United States 4 13 Triveni Bio, Third Arc Bio, BlossomHill Therapeutics
5 Advent International Boston, United States 2 17 Coralogix, KreditBee
6 SV Health Investors Boston, United States 1 9 Alchemab Therapeutics
7 Highland Capital Partners Lexington, United States 1 47 Tomorrow.io
8 Third Rock Ventures Boston, United States 1 5 Terremoto Biosciences
9 Bain Capital Boston, United States 1 27 Mintlify
10 K2 HealthVentures Boston, United States 1 1 Click Therapeutics
11 HarbourVest Partners Boston, United States 1 19 Varo Bank
12 Atlas Venture Cambridge, United States 1 47 Diagonal Therapeutics
13 Omega Funds Boston, United States 1 11 FoRx Therapeutics

Table 3. Post IPO investors in Massachusetts, United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M RA Capital Management 11 to 50 2019
Zipline International Unicorn Zipline designs, manufactures, and operates drones that deliver medical products. Hardware South San Francisco, United States Series I $1.5B 2026-11-05 $3.6B Fidelity 1,001 to 5,000 2011
Tenstorrent Unicorn Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. Artificial intelligence Santa Clara, United States Series E $1.5B 2026-10-19 $2.5B Fidelity 501 to 1,000 2016
SiMa.ai SiMa.ai develops hardware and software for deploying physical AI applications at the edge. Artificial intelligence San Jose, United States Series C $150.0M 2026-09-28 $505.0M Fidelity 101 to 250 2018
Baselayer Baselayer automates risk assessment and fraud detection for financial and government institutions. Artificial intelligence New York, United States Series A $35.0M 2026-09-22 $82.0M Founder Collective 51 to 100 2024
Superluminal Medicines Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. Artificial intelligence Boston, United States Series B $65.5M 2026-09-03 $223.5M RA Capital Management 11 to 50 2022
Claris Biotherapeutics Claris Biotherapeutics develops biologic therapies for corneal diseases and ocular surface disorders. Biotech Jersey City, United States Series B $118.0M 2026-07-28 $225.1M RA Capital Management 1 to 10 2018
Alchemab Therapeutics Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. Biotech London, United Kingdom Series A $33.6M 2026-07-09 $151.1M RA Capital Management, SV Health Investors 51 to 100 2019
Triveni Bio Triveni Bio develops antibody-based therapeutics for immunological and inflammatory diseases. Biotech Watertown, United States Series C $65.0M 2026-06-17 $272.0M Cormorant Asset Management 11 to 50 2019
Element Biosciences Unicorn Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. Biotech San Diego, United States Series E $277.0M 2026-06-09 $678.0M Fidelity, RA Capital Management 251 to 500 2017

Table 4. Post IPO investors in Massachusetts, United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 366 69%
Health care 139 26%
Biotech 107 20%
Hardware 104 20%
Artificial intelligence 76 14%
Commerce 60 11%
Fintech 52 10%
Cybersecurity 36 7%
Education 20 4%
Energy 8 2%

Table 5. Post IPO investors in Massachusetts, United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Post IPO investors in Massachusetts, United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Boston 33 69%
Cambridge 9 19%
Wellesley 2 4%
Lexington 1 2%
West Newton 1 2%
Waltham 1 2%
Springfield 1 2%

Table 7. Post IPO investors in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 1 2%
2010s 14 32%
2000s 9 20%
1990s 7 16%
1980s 9 20%
1970s 1 2%

Table 8. Post IPO investors in Massachusetts, United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many post ipo investors in Massachusetts, United States are on the list?
48, in the file dated 16 November 2026. 13 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
29 of the 48 carry an email address in the download and 35 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 48 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 48 rows, 29 firm email addresses and 35 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 18 of the 29 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Post IPO investors in Massachusetts, United States: 48 rows, CSV, $29 one-time.

At once: the CSV with 48 rows, 29 firm email addresses and 35 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 18 of the 29 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Post IPO investors by city in Massachusetts

Investor types in Massachusetts

Other stages in Massachusetts

Post IPO investors elsewhere

Cite: FundingWatcher, 48 post ipo investors in Massachusetts, United States, 16 November 2026. https://fundingwatcher.com/investors/stage/post-ipo-investors/massachusetts-united-states/